
    
      The proposed study is an eight-week double-blind randomized placebo-controlled parallel
      dose-finding study of CBD's effects on PTSD symptoms and neurocognitive function in 120
      patients with moderate to severe PTSD, 50% with comorbid mild-moderate TBI. There will be
      three arms, CBD 400 mg daily (n=40); CBD 600 mg daily (n=40) and placebo daily (n=40).
    
  